​Testimony of Jerome Paulson, MD, FAAP, on the impacts of air pollition and climate change on child health, before the U.S. House of Representatives Science, Space and Technology Committee

6/4/2015

​Testimony of AAP President Sandra G. Hassink, MD, FAAP before the Senate Agriculture Committee on child nutrition programs

5/7/2015

​AAP testimony for the record submitted to the Senate Appropriations Committee on behalf of James M. Perrin, MD, FAAP

Concerning the U.S. Government Response: Fighting Ebola and Protecting America

11/7/2014

​​Testimony of James. M. Perrin, MD, FAAP, before the Senate Finance Committee Health Care Subcommittee, on the Children's Health Insurance Program

9/16/2014

​Testimony of Susanne E. Tanski, MD, MPH, FAAP, before the Senate Committee on Commerce, Science and Transportation on Aggressive E-Cigarette Marketing and Potential Consequences for Youth

6/18/2014

​Testimony of Mark A. Gilger, MD, FAAP, before the Consumer Product Safety Commission on the child health and safety risks associated with high-powered magnet sets

10/22/2013

Testimony of Marcie Schneider, MD, FAAP, before Senate Committee on Commerce, Science, and Transportation:
“Energy Drinks: Exploring Concerns About Marketing to Youth”​

7/31/2013

​AAP Statement for the Record: U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health Medicaid Reform Hearing

7/8/2013

​Testimony of Lynda Young, MD, FAAP, before the Internal Revenue Service on its minimum essential coverage regulation

5/29/2013

Testimony of Kelly Moore, MD, FAAP, former chair, AAP Committee on Native American Child Health, before the House Appropriations Subcommittee on Interior, Environment, and Related Agencies: “Oversight Hearing- Indian Health”

3/19/2013

​AAP testimony for the record, submitted to the Senate Judiciary Subcommittee on the Constitution, Civil Rights and Human Rights: “Proposals to Reduce Gun Violence: Protecting Our Communities While Respecting the Second Amendment”

2/12/2013

AAP Testimony for the Record, Drug Shortages, before the U.S. Representatives Energy and Commerce Committee Health Subcommittee

2/9/2012

Testimony of Daniel A.C. Frattarelli, MD, FAAP,

AAP Committee on Drugs Chair Calls on Congress to Reauthorize Important Pediatric Drugs Laws

before the House Energy & Commerce Health Subcommittee

2/1/2012

​Testimony of Robert W. Block, MD, FAAP, AAP President

"Breaking the Silence on Child Abuse: Protection, Prevention, Intervention, and Deterrence"

before the U.S. Senate Health, Education, Labor and Pensions Committee

12/13/2011

​Testimony of David Isaac Bromberg, MD, FAAP

on the Health Insurance Premium Tax Credit Notice of Proposed Rulemaking

before the U.S. Internal Revenue Service

11/17/2011

​Testimony of Patience White, MD, MA, FAAP

Senior Department Officials Considering the Composition of Essential Health Benefits

before the U.S. Department of Health and Human Services 

10/18/2011

​Testimony of DeWayne M. Pursley, MD, MPH, FAAP

on Drug Shortages

before the Food and Drug Administration Center for Drug Evaluation and Research Drug Shortage Workshop

9/26/2011

Testimony of Jonathan P. Winickoff, MD, MPH, FAAP
on the Regulation of Dissolvable Tobacco Products
before the Food and Drug Administration Tobacco Products Scientific Advisory Committee

7/18/2011

Testimony of Jerome A. Paulson, MD, FAAP

"The Clean Air Act and Public Health"

before the U.S. Senate Environment and Public Works Committee

6/15/2011

​Testimony of Daniel A. Frattarelli, MD, FAAP

on Over-the-Counter Drug Products Containing Acetaminophen

before the Food and Drug Administration Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee

5/17/2011

Testimony of Michael R. Anderson, MD, FAAP, 

"A Nation Prepared: Strengthening Medical and Public Health Preparedness and Response"

before the U.S. Senate Committee on Health, Education, Labor and Pensions

5/17/2011

​Testimony of Daniel B. Fagbuyi, MD, FAAP

Taking Measure of Countermeasures Part 1

before the Subcommittee on Emergency Preparedness, Response, and Communications of the Homeland Security Committee

4/13/2011

​Testimony of Andrew Racine, MD, FAAP

before the Institute of Medicine Committee on Determination of Essential Health Benefits

1/14/2011

​Statement of Margaret J Blythe, MD, FAAP

before the Institute of Medicine's Committe on Preventive Services for Women

1/12/2011

​Testimony of H. Garry Gardner, MD, FAAP

on Oversight of the Consumer Product Safety Commission: Product Safety in the Holiday Season

before the Senate Commerce Science & Transportation Subcommittee on Consumer Protection, Product Safety & Insurance

12/2/2010

​Statement of Jonathan P. Winickoff, MD, MPH, FAAP

before the Food and Drug Administration Tobacco Products Scientific Advisory Committee

11/18/2010

Testimony of Joel S. Brenner, MD, MPH, FAAP

on ​Protecting School-Age Athletes from Sport-Related Concussion Injury

before the Committee on Energy and Commerce Health Subcommittee U.S. House of Representatives

 

9/8/2010

​Testimony of Daniel A.C. Frattarelli, MD, FAAP

before the Committee on Health, Education, Labor and Pensions U.S. Senate

7/21/2010

​Testimony of Judith S. Palfrey, MD, FAAP

on National Commission on Fiscal Responsibility and Reform

6/30/2010

Testimony of Sandra G. Hassink, MD, MPH, FAAP

on Childhood Obesity: Beginning the Dialogue on Reversing the Epidemic

before the Committee on Health, Education, Labor and Pensions U.S. Senate

3/4/2010

​Testimony of Sandra G. Hassink, MD, MPH, FAAP

on Innovations in Addressing Childhood Obesity

before the Energy and Commerce Subcommittee on Health U.S. House of Representatives

12/16/2009

​Testimony of Jerome A. Paulson, MD, FAAP

before the Environment and Public Works Committee U.S. Senate

12/8/2009

​Testimony of David T. Tayloe, Jr., MD, FAAP

on Challenges of the 2009-H1N1 Influenza and Its Potential Impact on
Small Businesses and Small Healthcare Practices

before the U.S. House of Representatives Committee on Small Business

9/9/2009

​Testimony of Susan Kressly, MD, FAAP

before the Committee on Small Business Subcommittee on Regulations and Healthcare U.S. House of Representatives

6/24/2009

​Testimony of Judith Palfrey, MD, FAAP President-Elect

before the Committee on Health, Education, Labor and Pensions U.S. Senate

6/11/2009

​Testimony of Marsha Raulerson, MD, FAAP

before the Committee on Health, Education, Labor and Pensions U.S. Senate

5/14/2009

​Testimony of Ruth A. Etzel, MD, PhD, FAAP

before the Commerce, Science and Transportation Subcommittee on Consumer Protection, Product Safety, and Insurance

4/28/2009

​Testimony of Joseph F. Hagan, Jr., MD, FAAP

on Access to Prevention and Public Health for High-Risk Populations

before the U.S. Senate Committee on Health, Education, Labor and Pensions

1/27/2009

Testimony of Mary Aitken
on Petition Requesting Ban on Sale of All-Terrain Vehicles Sold for Use of Children Under 16 Years Old

before the Consumer Product Safety Commission Public Meeting

​Pediatric Drug Testing Legislative and Regulatory History

​Safer Medicines for Children: The Need to Renew Pediatric Drug Testing Laws

Testimony of David Rubin, MD, MSCE, FAAP

on Foster Children and the Health Care System

before the House Ways and Means Committee on Income Security and Family Support Hearing